Clinical Trials Sponsored by Revivant Corporation

Total 6482 results

University of Washington
Revivant Corporation

Terminated

AutoPulse Assisted Prehospital International Resuscitation Trial (ASPIRE)

Cardiac Arrest

United States
Respivant Sciences GmbH
Respivant Sciences Inc.

Terminated

A Phase 2b Study of Inhaled RVT-1601 for the Treatment of Persistent Cough in IPF (SCENIC)

Chronic Cough | IPF | Persistent Cough in IPF

United States, United Kingdom, Netherlands, Australia, Belgium, New Zealand, Turkey, Italy, Germany, Czechia, Canada
Respivant Sciences GmbH
Respivant Sciences Inc.

Completed

Open-label Study of Inhaled RVT-1601 in Preterm Infants

Respiratory Morbidities of Prematurity (RMP)

United States
Relievant Medsystems, Inc.

Withdrawn

Intraosseous Basivertebral Nerve Ablation for the Treatment of Chronic Low Back Pain (CLBP)

Chronic Low Back Pain

United States
Relievant Medsystems, Inc.

Withdrawn

Intraosseous Basivertebral Nerve Ablation for Treatment of Chronic Low Back Pain (CLBP)

Chronic Low Back Pain

United States
Relievant Medsystems, Inc.

Completed

SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain (SMART)

Low Back Pain

United States
Relievant Medsystems, Inc.

Completed

INTRACEPT: Prospective, Randomized, Multi-center Study Intraosseous Basivertebral Nerve Ablation for Treatment of CLBP (CLBP)

Chronic Low Back Pain

United States
Relievant Medsystems, Inc.

Completed

Study of Basivertebral Nerve Ablation Treatment of Chronic Low Back Pain

Chronic Low Back Pain

United States
Relievant Medsystems, Inc.

Completed

Five-Plus Year Follow-Up of SMART Randomized Controlled Trial (SMART)

Chronic Low Back Pain

United States
Reviva Pharmaceuticals

Recruiting

Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia (RECOVER)

Schizophrenia

United States
Reviva Pharmaceuticals

Completed

RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder (REFRESH)

Schizoaffective Disorder | Acute Schizophrenia

United States, India, Malaysia, Moldova, Republic of, Philippines
Invitrox
Reliant Pharmaceuticals

Completed

Lovaza's Effect on the Activation of Platelets (LEAP)

Cardiovascular Disease | Bleeding
University of Utah
Relievant Medsystems

Suspended

Intracept Intraosseous Basivertebral Nerve Ablation

Low Back Pain

United States
Penn State University
Reliant Pharmaceuticals

Completed

Vascular and Lipid Effects of Omega-3 Fatty Acids in People With Moderately Elevated Triglycerides (OMEGA)

Hypertriglyceridemia

United States
University of Arizona
Reliant Pharmaceuticals

Withdrawn

Omacor for Perimenopausal Depression

Depression

United States
Provident Clinical Research
Reliant Pharmaceuticals

Completed

An Evaluation of Simvastatin Plus Omacor Compared to Simvastatin Plus Placebo in Subjects With Mixed Dyslipidemia

Mixed Dyslipidemia
GenMont Biotech Incorporation
Biomedical Development Corporation

Completed

the Efficacy and Safety of Probiotics eN-Lac® Capsules of Children With Perennial Allergic Rhinitis (PAR)

Probiotics | Perennial Allergic Rhinitis | Lactobacillus Paracasei GMNL-32 (eN-Lac®)

Taiwan
Provident Clinical Research
Reliant Pharmaceuticals

Unknown

An Open-Label Extension to Assess the Continued Efficacy of Omacor Plus Simvastatin

Mixed Dyslipidemia
Revival Active
Aarogyam UK; L.E.A.D

Completed

A Clinical Study of Online Active Play Program With Adolescents

Depression | Anxiety

United Kingdom
University of Virginia
Reliant Pharmaceuticals

Withdrawn

Lovaza Therapy of Peripheral Arterial Disease

Peripheral Artery Disease

United States
Kinevant Sciences GmbH
Roivant Sciences, Inc.

Completed

A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE)

COVID-19

United States
Relievant Medsystems, Inc.
M Squared Associates,Inc.

Terminated

The Intracept Global Registry ( TIGR ) - Pilot Study

Low Back Pain

United States
Revival Active
NMP Medical Research Institute; L.E.A.D

Completed

Revival Active Program for Adolescents With Depression

Depression

India
Lebanese University
Reviva Regenerative Medicine Center MEIH Hospital - REVIVA PHARMACEUTICALS...

Unknown

Autologous Adipose-Derived Adult Stromal Vascular Cell Transplantation for Alopecia (A-ADSVC-CT-A)

Alopecia | Hair Loss/Baldness

Lebanon
Tilburg University
Fonds NutsOhra; Revant Schoondonck Center for Pulmonary Rehabilitation Breda; Revant Innovation foundation

Completed

Pulmonary Rehabilitation: Effects on Cognitive Functioning, Mood, Anxiety, and Quality of Life in Patients With COPD

Chronic Obstructive Pulmonary Disease COPD

Netherlands
Olive View-UCLA Education & Research Institute
Reliant Pharmaceuticals

Completed

The Effect of Fish Oil Supplementation on Endothelial Function, Heart Rate Variability and Intimal Media Thickness of Patients With Coronary Artery Disease

Coronary Artery Disease

United States
University of Massachusetts, Worcester
Pfizer; Reliant Medical Group

Completed

System Alignment for VaccinE Delivery (SAVED): Improving Rates of Influenza and Pneumococcal Vaccination Through Patient Outreach, Improved Medical Record Accuracy and Targeted Physician Alerts

Influenza | Infections, Pneumococcal

United States
Relievant Medsystems, Inc.
M Squared Associates,Inc.; ProPharma Group

Completed

CLBP Single-Arm Long-Term Follow-up Study

Chronic Low Back Pain

United States
Boston Scientific Corporation
Guidant Corporation

Completed

Septal - Success Rate and Clinical Outcome of Septal Implant of Ventricular Defibrillation Lead

Ventricular Fibrillation | Ventricular Tachycardia

France
Boston Scientific Corporation
Guidant Corporation

Completed

Shockless Implant Evaluation (SIMPLE)

Ventricular Fibrillation | Ventricular Tachycardia

Germany, Spain, Canada, Israel, Netherlands, France, Finland, United Kingdom, Austria, Malaysia, Thailand, Hong Kong, Sweden, Hungary, Australia, Czechia, Norway, Poland
Boston Scientific Corporation
Guidant Corporation

Completed

Feature Assessment Study for Indications Based Programming (FASt-IBP)

Heart Failure | Ventricular Fibrillation | Ventricular Tachycardia | Ventricular Flutter

Germany, Spain, Switzerland, China, Austria, Belgium, France, Greece, Latvia, Netherlands, Slovakia
Boston Scientific Corporation
Guidant Corporation

Completed

Japanese Assessment of Indication Based Programming (JASMINE)

Heart Failure | Arrhythmias, Cardiac

Japan
Boston Scientific Corporation
Guidant Corporation

Completed

Quick ICD Study: Is Extensive Electrophysiological Testing Before, During and After ICD-Implantation Still Necessary ? (Quick ICD)

Cardiac Arrest

Germany
Rgene Corporation
American BriVision Corporation

Not yet recruiting

Evaluate the Safety and Efficacy of BLEX 404 Oral Liquid Combined With Pemetrexed + Cisplatin Therapy

Nonsquamous Nonsmall Cell Neoplasm of Lung

Taiwan
Rgene Corporation
American BriVision Corporation

Not yet recruiting

A Phase II, EvaluateBLEX 404 Combined With Gemcitabine Monotherapy With Pancreatic Cancer

Pancreatic Cancer
Boston Scientific Corporation
Guidant Corporation

Terminated

MODULA Modul 7 VRR

Atrial Fibrillation

Germany
Boston Scientific Corporation
EKOS Corporation

Completed

ULTrasound Accelerated ThrombolysIs of PulMonAry Embolism (ULTIMA)

Submassive Pulmonary Embolism

Germany, Switzerland
Boston Scientific Corporation
EKOS Corporation

Completed

Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Pulmonary Embolism (OPTALYSE PE)

Pulmonary Embolism and Thrombosis

United States, United Kingdom
Boston Scientific Corporation
EKOS Corporation

Completed

Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy (SEATTLE II)

Pulmonary Embolism | Acute Pulmonary Embolism | Pulmonary Thromboembolism | Massive Pulmonary Embolism | Sub-massive Pulmonary Embolism

United States
Boston Scientific Corporation
Guidant Corporation

Completed

MODULA Modul 5 BEAT-HF

Heart Failure

Germany
Boston Scientific Corporation
Guidant Corporation

Terminated

MODULA-Study: Modul 10: Benefit of CRT-Therapy in CRT-Patients With QRS-Complex of 120 - 150 Ms

Heart Failure

Germany
Guidant Corporation
Boston Scientific Corporation

Completed

Cognis and Teligen 100 HE and Reliance Quadripolar Defibrillation Lead (4-Site) Field Following (Cogent-4)

Heart Failure | Ventricular Tachycardia, Ventricular Fibrillation

Israel, Denmark
Boston Scientific Corporation
EKOS Corporation

Withdrawn

Registry Study to Evaluate the Performance and Safety of Roxwood Medical Catheters in Arteries of Participants With a Stenotic Lesion or Chronic Total Occlusion (CTO)

Coronary Artery Disease | Atherosclerosis | Peripheral Artery Disease | Chronic Total Occlusion

United States
Boston Scientific Corporation
EKOS Corporation

Completed

Treatment of Chronic Deep Vein Thrombosis (DVT) and Post-Thrombotic Syndrome (PTS) With the EkoSonic® Endovascular System (ACCESS PTS)

Deep Vein Thrombosis | Post-thrombotic Syndrome

United States
Guidant Corporation
Boston Scientific Corporation

Completed

Comparison of Right Ventricular Septal and Right Ventricular Apical Pacing in Patients Receiving a CRT-D Device (SEPTAL-CRT)

Ventricular Fibrillation | Ventricular Tachycardia | Systolic Heart Failure

France, Spain
Shanghai Antengene Corporation Limited

Terminated

A Study to Evaluating the Pharmacokinetics, Safety, and Efficacy of ATG 016 Monotherapy in IPSS-R Intermediate Risk and Above Myelodysplastic Syndrome (MDS) (HATCH)

Myelodysplastic Syndrome

China
Shanghai Antengene Corporation Limited

Terminated

A Study of Evaluating the Safety and Efficacy of ATG-008 for Advanced Solid Tumors (BUNCH)

Advanced Solid Tumors

China
Shanghai Antengene Corporation Limited

Terminated

A Study to Assess the Safety, Pharmacokinetics, and Preliminary Efficacy of ATG 016 Monotherapy in Patients With Advanced Solid Tumors (REACH)

Advanced Solid Tumors

China
Mitsubishi Tanabe Pharma Corporation
Kureha Corporation

Completed

A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease (EPPIC-1)

Chronic Kidney Disease

United States, France, Italy, Ukraine, Argentina, Mexico, Poland, Canada, Brazil, Russian Federation, Czechia, Puerto Rico
Mitsubishi Tanabe Pharma Corporation
Kureha Corporation

Completed

A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease Including Assessment of Quality of Life (EPPIC-2)

Chronic Kidney Disease

United States, Poland, Ukraine, Spain, Argentina, Mexico, Canada, Brazil, Russian Federation, Puerto Rico, Germany, Czechia

Clinical Trials Sponsored by Revivant Corporation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations